COVID-19, tuberculosis and poverty: preventing a perfect storm

Matthew J Saunders, Carlton A Evans, Matthew J Saunders, Carlton A Evans

Abstract

The global health community must learn from COVID-19 and take action now on tuberculosis and its social determinants, potentially saving millions from a preventable and curable disease https://bit.ly/2LLgLgA

Conflict of interest statement

Conflict of interest: M.J. Saunders has nothing to disclose. Conflict of interest: C.A. Evans has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Mechanisms by which the COVID-19 pandemic is expected to worsen the tuberculosis (TB) pandemic.

References

    1. United Nations Development Programme COVID-19: Looming Crisis in Developing Countries Threatens to Devastate Economies and Ramp Up Inequality. 2020. Date last accessed: 9 April, 2020.
    1. Sumner A, Hoy C, Ortiz-Juarez E. Estimates of the Impact of COVID-19 on Global Poverty. WIDER Working Paper 2020/43 Helsinki, UNU-WIDER, 2020.
    1. Hogan AB, Jewell B, Sherrard-smith E, et al. . The Potential Impact of the COVID-19 Epidemic on HIV, TB and Malaria in Low- and Middle-Income Countries. London, Imperial College London, 2020. doi:10.25561/78670
    1. World Health Organization Global Tuberculosis Report 2019. Geneva, World Health Organization, 2019.
    1. Wingfield T, Tovar MA, Datta S, et al. . Addressing social determinants to end tuberculosis. Lancet 2018; 391: 1129–1132. doi:10.1016/S0140-6736(18)30484-7
    1. Saunders MJ, Evans CA. Fighting poverty to prevent tuberculosis. Lancet Infect Dis 2016; 16: 395–396. doi:10.1016/S1473-3099(15)00434-X
    1. Wingfield T, Boccia D, Tovar MA, et al. . Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med 2014; 11: e1001675. doi:10.1371/journal.pmed.1001675
    1. Carter DJ, Glaziou P, Lönnroth K, et al. . The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of Sustainable Development Goal 1. Lancet Glob Heal 2018; 6: e514–e522. doi:10.1016/S2214-109X(18)30195-5
    1. Siroka A, Ponce NA, Lönnroth K. Association between spending on social protection and tuberculosis burden: a global analysis. Lancet Infect Dis 2016; 16: 473–479. doi:10.1016/S1473-3099(15)00401-6
    1. Dye C, Lönnroth K, Jaramillo E, et al. . Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ 2009; 87: 683–691. doi:10.2471/BLT.08.058453
    1. Saunders MJ, Evans CA. Ending tuberculosis through prevention. N Engl J Med 2019; 380: 1073–1074. doi:10.1056/NEJMe1901656
    1. Bonadonna LV, Saunders MJ, Zegarra R, et al. . Why wait? The social determinants underlying tuberculosis diagnostic delay. PLoS One 2017; 12: e0185018. doi:10.1371/journal.pone.0185018
    1. Datta S, Evans CA. Healthy survival after tuberculosis. Lancet Infect Dis 2019; 19: 1045–1047. doi:10.1016/S1473-3099(19)30387-1
    1. Yuen CM, Amanullah F, Dharmadhikari A, et al. . Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment. Lancet 2015; 386: 2334–2343. doi:10.1016/S0140-6736(15)00322-0
    1. Saunders MJ, Wingfield T, Tovar MA, et al. . A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort study. Lancet Infect Dis 2017; 17: 1190–1199. doi:10.1016/S1473-3099(17)30447-4
    1. Saunders MJ, Wingfield T, Datta S, et al. . A household-level score to predict the risk of tuberculosis among contacts of patients with tuberculosis: a derivation and external validation prospective cohort study. Lancet Infect Dis 2020; 20: 110–122. doi:10.1016/S1473-3099(19)30423-2
    1. World Health Organization Information Note: Tuberculosis and COVID-19. Geneva, World Health Organization, 2020.
    1. Rudgard WE, Evans CA, Sweeney S, et al. . Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: an economic modelling study. PLoS Med 2017; 14: e1002418. doi:10.1371/journal.pmed.1002418
    1. Wingfield T, Boccia D, Tovar MA, et al. . Designing and implementing a socioeconomic intervention to enhance TB control: operational evidence from the CRESIPT project in Peru. BMC Public Health 2015; 15: 810. doi:10.1186/s12889-015-2128-0
    1. Datta S, Gilman R, Montoya R, et al. . Quality of life, tuberculosis and treatment outcome; a case-control and nested cohort study. Eur Respir J 2020; in press []. doi:10.1183/13993003.00495-2019
    1. Saunders MJ, Wingfield T, Tovar MA, et al. . Mobile phone interventions for tuberculosis should ensure access to mobile phones to enhance equity ′ a prospective, observational cohort study in Peruvian shantytowns. Trop Med Int Health 2018; 23: 850–859. doi:10.1111/tmi.13087
    1. Wingfield T, Tovar MA, Huff D, et al. . A randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru. Bull World Health Organ 2017; 95: 270–280. doi:10.2471/BLT.16.170167
    1. Saunders MJ, Datta S, Wingfield T, et al. . Socioeconomic support to improve tuberculosis screening and preventive therapy completion in tuberculosis-affected households in Peru: a cluster randomised trial. Int J Tuberc Lung Dis 2019; 23: S581.
    1. Wingfield T, Tovar MA, Huff D, et al. . The economic effects of supporting tuberculosis-affected households in Peru. Eur Respir J 2016; 48: 1396–1410. doi:10.1183/13993003.00066-2016
    1. Tadolini M, Codecasa L, Garcia-Garcia J, et al. . Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J 2020; 56: 2001398.
    1. Datta S, Saunders MJ, Tovar MA, et al. . Improving tuberculosis diagnosis: better tests or better healthcare? PLoS Med 2017; 14: 4–7. doi:10.1371/journal.pmed.1002406
    1. Rangaka MX, Cavalcante SC, Marais BJ, et al. . Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet 2015; 386: 2344–2353. doi:10.1016/S0140-6736(15)00323-2
    1. Saunders MJ, Tovar MA, Collier D, et al. . Active and passive case-finding in tuberculosis-affected households in Peru: a 10-year prospective cohort study. Lancet Infect Dis 2019; 19: 519–528. doi:10.1016/S1473-3099(18)30753-9
    1. Treatment Action Group, Stop TB Partnership Tuberculosis Research Funding Trends 2005–2017. New York, Treatment Action Group, 2018.
    1. Brandt A, Botelho A. Not a perfect storm – COVID-19 and the importance of language. N Engl J Med 2020; 382: 1493–1495. doi:10.1056/NEJMp2005032

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj